ReviewCurrent rheumatology reports2006
Myositis specific autoantibodies.
Review in Current rheumatology reports, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 97 citations in OpenAlex.
- IL-17-driven transcriptional programs in muscle fibroblasts are not required for pathogenesis in murine anti-histidyl-tRNA synthetase (Jo-1) myositis.Journal of immunology (Baltimore, Md. : 1950) · 2026Article
- Gene variants of interferon induced with helicase C domain 1 in Japanese patients with Dermatomyositis-associated rapidly progressive interstitial lung disease: a genetic association study using whole-exome and Sanger sequencing.Respiratory research · 2025Article
- Dermatomyositis associated with gestational trophoblastic neoplasia: a case report.Annals of medicine and surgery (2012) · 2025Article
- Enhanced immune complex formation in the lungs of patients with dermatomyositis.Respiratory research · 2023Article
- Environmental factors associated with juvenile idiopathic inflammatory myopathy clinical and serologic phenotypes.Pediatric rheumatology online journal · 2022Article
- Autoantibodies in Myositis. How to Achieve a Comprehensive Strategy for Serological Testing.Mediterranean journal of rheumatology · 2019Review
- Idiopathic Inflammatory Myopathies and Malignancy: a Comprehensive Review.Clinical reviews in allergy & immunology · 2017Review
- The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis: a Critical Review.Clinical reviews in allergy & immunology · 2017Review
- Signal recognition particle immunoglobulin g detected incidentally associates with autoimmune myopathy.Muscle & nerve · 2016Article
- Autoantigens as Partners in Initiation and Propagation of Autoimmune Rheumatic Diseases.Annual review of immunology · 2016Review
- Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathies.The Journal of clinical investigation · 2015Article
- Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1γ antibodies in adults with dermatomyositis.Journal of the American Academy of Dermatology · 2015Article
- Anti-transcription intermediary factor 1-gamma autoantibody ELISA development and validation.Rheumatology (Oxford, England) · 2014Article
- Functional redundancy of MyD88-dependent signaling pathways in a murine model of histidyl-transfer RNA synthetase-induced myositis.Journal of immunology (Baltimore, Md. : 1950) · 2013Article
- Polymyositis and dermatomyositis: Disease spectrum and classification.Indian journal of dermatology · 2012Article
- Inflammatory myopathy and severe rhabdomyolysis induced by leuprolide acetate therapy for prostate cancer: a case report.Journal of medical case reports · 2011Article
- Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.Nature reviews. Neurology · 2011Review
- Pancreatic adenocarcinoma-associated polymyositis treated with corticosteroids along with cancer specific treatment: case report.BMC gastroenterology · 2011Article
- Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan.Arthritis research & therapy · 2010Article
- Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease.Arthritis and rheumatism · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent studies have continued to examine the clinical associations of the group of autoantibodies that occurs predominantly in patients who have myositis (antibodies to aminoacyl-tRNA synthetases, to signal recognition particle [SRP], and to the nuclear helicase Mi-2). The anti-synthetase syndrome has been further studied, and the value of tacrolimus in treatment of the associated interstitial lung disease has been noted. The low frequency of myositis specific autoantibodies in non-myositis neuromuscular disorders has been more clearly demonstrated. The clinical associations of anti-Mi-2 and anti-SRP were further studied, and patients with antibodies without myositis were reported. Evidence suggested that ultraviolet light exposure may influence the expression of dermatomyositis and anti-Mi-2. A new classification for myositis using overlap clinical features and autoantibodies was proposed. A new autoantibody, anti-caDM-140, was described, associated with clinically amyopathic dermatomyositis and interstitial lung disease. The possibility was raised that increased antigen expression in regenerating muscle may help to perpetuate the disease. These antibodies continue to be the subject of active investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.